Skip to content

Prospective Melanoma Database

Creation of a Prospective Melanoma Database

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02884362
Enrollment
10000
Registered
2016-08-31
Start date
2016-01-31
Completion date
2026-06-30
Last updated
2016-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Melanoma

Keywords

melanoma clinical biological database

Brief summary

In research on melanoma, translational research is the essential link between basic research and clinical research by facilitating the passage between discovery and improvement in the quality of patients care.That is the reason why it is very important to collect, and centralize clinical and biological data of patients with melanoma. The aim of the project is to provide to scientific community a structured, mixed clinical and biological database, unique in France, in order to insure accessibility to clinical data.

Detailed description

collection of clinical and biological data from patients with melanomas of any stage in a structured and centralized database

Interventions

OTHERclinical biological data collection on melanoma

collection and centralization of clinical and biological data of patients with melanoma

Sponsors

Institut Claudius Regaud
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 18 years * Histologically confirmed melanoma of any stage * Affiliated to a social security system in france * Who signed the informed consent

Exclusion criteria

* Any psychiatric or medical condition that would make the patient unable to give a signed informed consent

Design outcomes

Primary

MeasureTime frame
Database of patients with melanoma10 years

Countries

France

Contacts

Primary ContactNicolas MEYER, MD PHD
Meyer.Nicolas@iuct-oncopole.fr5 31 15 51 61

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026